373110.KQ
Xcell Therapeutics, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 1,120.00
−2.44%Leverage
- Debt / equity
- 1.24x
- Net debt / equity
- 0.34x
- Debt / assets
- 0.43x
- Debt / EBITDA
- -0.55x
- Net debt / EBITDA
- -0.15x
Liquidity & coverage
- Current ratio
- 1.28x
- Quick ratio
- 1.07x
- Cash ratio
- 0.82x
- Interest coverage
- -28.80x
- EBITDA / interest
- -20.12x
- Working capital
- KRW 1.4B
Cash & dividend
- FCF / debt
- -1.94x
- Cash flow / debt
- -1.90x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026